Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Babylon Holdings Limited (BBLNF)
London, GB
Babylon Holdings Limited operated as a digital healthcare company, providing comprehensive, end-to-end care solutions. These offerings included a sophisticated digital health platform, virtual consultations, in-person medical services, and subsequent post-care support, notably featuring its proprietary Babylon Cloud and various clinical services. Established in 2013, the company was headquartered in Austin, Texas. A significant event occurred on August 9, 2023, when Babylon Inc., along with an affiliate, filed a voluntary petition for Chapter 7 liquidation in the U.S. Bankruptcy Court for the District of Delaware.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | -99.99% | -100.00% | -100.00% | -100.00% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | -1 |
| Sell | 0 | 0 |
| Strong Sell | 1 | 0 |
-
Revenue growth Medical - Healthcare Information Services: +14.2%+245.9% ★ Q1'23: +16.8% (vs Q1'22)
-
EPS growth Medical - Healthcare Information Services: +43.1%+93.1% ★ Q1'23: +57.4% (vs Q1'22)
-
FCF margin FCF growth · Medical - Healthcare Information Services: +49.2%-22.0% Q1'23: -13.5% (vs Q1'22)
-
EBIT margin Medical - Healthcare Information Services: +8.8%-17.0% Q1'23: -17.5% (vs Q1'22)
-
ROIC Medical - Healthcare Information Services: +5.2%— Q1'23: +800.5% (vs Q1'22)
-
Share dilution Medical - Healthcare Information Services: -0.1%+4,027.2% Q1'23: +62.7% (vs Q1'22)
-
Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Information Services: -0.74×-1.68× Q1'23: -1.47× (vs Q1'22)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|
| Revenue |
320.83M
est: 319.28M (+0.5%)
|
1.11B
est: 1.11B (-0.1%)
|
1.04B
est.
|
943.71M
est.
|
1.67B
est.
|
3.35B
3.35B – 3.35B
+100.4% YoY
|
| EBITDA |
-62.65M
est: -187.94M (+66.7%)
|
-176.73M
est: -653.83M (+73.0%)
|
-611.12M
est.
|
-555.50M
est.
|
-983.75M
est.
|
-1.97B
-1.97B – -1.97B
-100.4% YoY
|
| EBIT |
-71.83M
est: -191.09M (+62.4%)
|
-188.78M
est: -664.79M (+71.6%)
|
-621.37M
est.
|
-564.82M
est.
|
-1.00B
est.
|
-2.00B
-2.00B – -2.00B
-100.4% YoY
|
| Net Income |
-77.41M
est: -237.30M (+67.4%)
|
-221.45M
est: -258.15M (+14.2%)
|
-146.59M
est.
|
-111.37M
est.
|
-88.21M
est.
|
-258.15M
-258.15M – -258.15M
-192.6% YoY
|
| SGA |
187.17M
est: 536.15M (-65.1%)
|
227.94M
est: 1.87B (-87.8%)
|
1.74B
est.
|
1.58B
est.
|
2.81B
est.
|
5.62B
5.62B – 5.62B
+100.4% YoY
|
| EPS |
-173.26
est: -12.87 (-1,246.3%)
|
-12.01
est: -14.00 (+14.2%)
|
-7.95
est.
|
-6.04
est.
|
-4.78
est.
|
-14.00
-14.00 – -14.00
-192.6% YoY
|
Owner Earnings
Ownership Overview
Ownership breakdown not available.
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Invik S.A. | 115.43M | 18.60% | 115.43M | — | 115.43M | 10.00 | CO | Luxembourg | 2022-11-14 | ↗ |
| 2 | Kinnevik AB (publ) | 115.43M | 18.60% | 115.43M | — | 115.43M | 10.00 | CO | Sweden | 2022-11-14 | ↗ |
| 3 | VNV Global AB (publ) | 100.87M | 16.30% | — | 100.87M | — | 10.00 | CO | Sweden | 2022-11-10 | ↗ |
| 4 | VNV (Cyprus) Limited | 83.12M | 13.40% | 83.12M | — | 83.12M | 10.00 | CO | Cyprus | 2022-11-10 | ↗ |
| 5 | The Public Investment Fund | 35.41M | 8.60% | 35.41M | — | 35.41M | — | OO | Kingdom of Saudi Arabia | 2022-02-14 | ↗ |
| 6 | Global Health Equity (Cyprus) Ltd | 17.75M | 2.90% | 17.75M | — | 17.75M | 10.00 | CO | Cyprus | 2022-11-10 | ↗ |
| 7 | VNV Sweden AB | 17.75M | 2.90% | — | 17.75M | — | 10.00 | CO | Sweden | 2022-11-10 | ↗ |
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Aron England | Chief Product Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for BBLNF
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
